Cytokinetics, Incorporated
CYTK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$590 | -$526 | -$389 | -$215 |
| Dep. & Amort. | $10 | $12 | $6 | $2 |
| Deferred Tax | $0 | $0 | $0 | $3 |
| Stock-Based Comp. | $98 | $72 | $48 | $27 |
| Change in WC | $36 | $3 | -$25 | $8 |
| Other Non-Cash | $51 | $25 | $60 | $32 |
| Operating Cash Flow | -$396 | -$414 | -$300 | -$143 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$1 | -$11 | -$49 |
| Net Acquisitions | $0 | $0 | $251 | $99 |
| Inv. Purchases | -$1,293 | -$635 | -$855 | -$525 |
| Inv. Sales/Matur. | $744 | $876 | $605 | $426 |
| Other Inv. Act. | $0 | $0 | -$251 | -$99 |
| Investing Cash Flow | -$553 | $239 | -$262 | -$148 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10 | -$1 | $335 | $0 |
| Stock Issued | $707 | $164 | $18 | $312 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $233 | $58 | $164 | $8 |
| Financing Cash Flow | $931 | $221 | $516 | $320 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$18 | $46 | -$45 | $30 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $113 | $67 | $113 | $83 |
| End Cash | $95 | $113 | $67 | $113 |
| Free Cash Flow | -$400 | -$416 | -$311 | -$191 |